Ooplasmic injection of elongating spermatids for the treatment of non- obstructive azoospermia
Author(s) -
Nikolaos Sofikitis,
Yasuhisa Yamamoto,
Ikuo Miyagawa,
G. Mekras,
Yasuyuki Mio,
T. Toda,
S. Antypas,
Hiroshi Kawamura,
N. Kanakas,
N Antoniou,
D. Loutradis,
Themis Mantzavinos,
K Kalianidis,
E. Agapitos
Publication year - 1998
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/13.3.709
Subject(s) - spermatid , andrology , azoospermia , spermatocyte , obstructive azoospermia , embryo , intracytoplasmic sperm injection , biology , spermatogenesis , meiosis , medicine , microbiology and biotechnology , infertility , pregnancy , in vitro fertilisation , genetics , gene
We applied the technique of ooplasmic elongating spermatid injection to the treatment of non-obstructive azoospermia. Mature oocytes were injected with elongating spermatids isolated from testicular biopsy material obtained from 13 non-obstructed azoospermic men. Seventy-three oocytes were successfully injected with elongating spermatids and were then cultured for 36 h. At 13 h post-injection 68 oocytes were found to be activated and 52 of them were fertilized. Forty-one 2- to 4-cell stage embryos developed from normally fertilized oocytes were transferred. At least two embryos were transferred to each female partner. Two pregnancies were achieved. Elongating spermatid injection may have a role in the treatment of non-obstructive azoospermia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom